• Clinical Evidence

Implementation of Glucose Management Software in Cardiac Surgery Patients to Improve Postoperative Blood Glucose Control and Compliance with SCIP Measures

Objective

This retrospective observational study compares SCIP-Inf-4 compliance among cardiac surgery patients before and after implementation of a glucose management software system (EndoTool).

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results

  • After implementation of EndoTool, percentage of patients in full SCIP-Inf-4 compliance increased from 86.1% to 89.9%, while percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 88.9% to 96.1%.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool after less than 30 hours of continuous intravenous insulin therapy.

Conclusions

Use of EndoTool for post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections); however, early discontinuation of patients from EndoTool prior to completing a full 48 hours of continuous intravenous insulin therapy has a negative effect on SCIP-Inf-4 compliance.

Objective

This retrospective observational study compares SCIP-Inf-4 compliance among cardiac surgery patients before and after implementation of a glucose management software system (EndoTool).

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results
  • After implementation of EndoTool, percentage of patients in full SCIP-Inf-4 compliance increased from 86.1% to 89.9%, while percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 88.9% to 96.1%.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool after less than 30 hours of continuous intravenous insulin therapy.
Conclusions

Use of EndoTool for post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections); however, early discontinuation of patients from EndoTool prior to completing a full 48 hours of continuous intravenous insulin therapy has a negative effect on SCIP-Inf-4 compliance.

References

Authors

Amanda Zomp, PharmD; Earnest Alexander, PharmD, FCCM; Maresa Glass, PharmD, BCPS; Ren Chen, MD, MPH.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 39, Issue 12, p206.

Year

2012

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective observational study compares SCIP-Inf-4 compliance among cardiac surgery patients before and after implementation of a glucose management software system (EndoTool).

Setting

1,018-bed academic medical center and Level 1 trauma center.

Results
  • After implementation of EndoTool, percentage of patients in full SCIP-Inf-4 compliance increased from 86.1% to 89.9%, while percentage of patients in SCIP-Inf-4 compliance post-operative Day 1 increased from 88.9% to 96.1%.
  • Among patients in SCIP-Inf-4 compliance post-operative Day 1 but not post-operative Day 2, all (100%) had been discontinued from EndoTool after less than 30 hours of continuous intravenous insulin therapy.
Conclusions

Use of EndoTool for post-operative glucose management of cardiac surgery patients leads to improved SCIP-Inf-4 compliance (a program that aims to decrease incidence of surgical site infections); however, early discontinuation of patients from EndoTool prior to completing a full 48 hours of continuous intravenous insulin therapy has a negative effect on SCIP-Inf-4 compliance.

References

Authors

Amanda Zomp, PharmD; Earnest Alexander, PharmD, FCCM; Maresa Glass, PharmD, BCPS; Ren Chen, MD, MPH.

Source

Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 39, Issue 12, p206.

Year

2012

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.